Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 742G5 | — |
patient received only the diluent portion; patient received only the diluent portion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 9-month-old male patient who received Hib (Hiberix) (batch number 742G5, expiry date 26-AUG-2026) for prophylaxis. On 02-AUG-2025, the patient received Hiberix. On 02-AUG-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the diluent portion) and inappropriate dose of vaccine administered (Verbatim: patient received only the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 05-AUG-2025 The reporter mentioned that a patient received only the diluent portion of Hiberix. The reporter was aware that the diluent is sterile saline solution. The patient received only adjuvant of Hiberix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.